Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|March 14, 2017
Measuring and Altering Mating Drive in Male Drosophila melanogasterChristine L Boutros, Lauren E Miner, Ofer Mazor, et al.Neuron|July 10, 2018
Motivation, Perception, and Chance Converge to Make a Binary DecisionStephen X Zhang, Lauren E Miner, Christine L Boutros, et al.Sleep|March 30, 2021
HIV increases sleep-based brain age despite antiretroviral therapyMichael J Leone, Haoqi Sun, Christine L Boutros, et al.Plos One|November 15, 2019
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsidsQin Huang, Ken Y Chan, Isabelle G Tobey, et al.Science Translational Medicine|July 27, 2022
Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized miceJacqueline M Brady, Meredith Phelps, Scott W MacDonald, et al.Emerging Infectious Diseases|December 27, 2022
Successful Treatment of Balamuthia mandrillaris Granulomatous Amebic Encephalitis with NitroxolineNatasha Spottiswoode, Douglas Pet, Annie Kim, et al.Frontiers in Neurology|April 26, 2021
Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19Shibani S Mukerji, Sudeshna Das, Haitham Alabsi, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapyNicolas M S Galvez, Yi Cao, Adam D Nitido, et al.The Journal of Infectious Diseases|October 24, 2020
CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 PrognosisHaoqi Sun, Aayushee Jain, Michael J Leone, et al.Immunity|February 26, 2026
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized miceNicolas M S Galvez, Adam D Nitido, Seo Bin Yoo, et al.Pageof 1